Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Kim A MaciolekE Jason AbelNatasza M PosielskiJ Louis HinshawMeghan G LubnerFred T LeeTimothy J ZiemlewiczShane A WellsPublished in: European radiology (2019)
• The safety profile for percutaneous microwave ablation of anterior and posterior T1a renal cell carcinoma is equivalent. • Percutaneous microwave ablation of T1a renal cell carcinoma provides durable oncologic control regardless of tumor location. • Placement of additional microwave antennas and use of hydrodisplacement are associated with longer procedure times.